Cargando…

Cerebral Biomarkers and Blood-Brain Barrier Integrity in Preeclampsia

Cerebral complications in preeclampsia contribute substantially to maternal mortality and morbidity. There is a lack of reliable and accessible predictors for preeclampsia-related cerebral complications. In this study, plasma from women with preeclampsia (n = 28), women with normal pregnancies (n =...

Descripción completa

Detalles Bibliográficos
Autores principales:	Friis, Therese, Wikström, Anna-Karin, Acurio, Jesenia, León, José, Zetterberg, Henrik, Blennow, Kaj, Nelander, Maria, Åkerud, Helena, Kaihola, Helena, Cluver, Catherine, Troncoso, Felipe, Torres-Vergara, Pablo, Escudero, Carlos, Bergman, Lina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909006/ https://www.ncbi.nlm.nih.gov/pubmed/35269411 http://dx.doi.org/10.3390/cells11050789

Ejemplares similares

Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia - A nested case control study
por: Bergman, Lina, et al.
Publicado: (2018)

Plasma Levels of S100B in Preeclampsia and Association With Possible Central Nervous System Effects
por: Bergman, Lina, et al.
Publicado: (2014)

Evidence of Neuroinflammation and Blood–Brain Barrier Disruption in Women with Preeclampsia and Eclampsia
por: Bergman, Lina, et al.
Publicado: (2021)

Editorial: Preeclampsia and the brain: Pre-clinical and clinical studies of cerebral involvement in preeclampsia
por: Bergman, Lina, et al.
Publicado: (2023)

Signs of neuroaxonal injury in preeclampsia—A case control study
por: Andersson, Malin, et al.
Publicado: (2021)

Potential Role of A(2B) Adenosine Receptors on Proliferation/Migration of Fetal Endothelium Derived from Preeclamptic Pregnancies
por: Acurio, Jesenia, et al.
Publicado: (2014)

Are the Cognitive Alterations Present in Children Born From Preeclamptic Pregnancies the Result of Impaired Angiogenesis? Focus on the Potential Role of the VEGF Family
por: Lara, Evelyn, et al.
Publicado: (2018)

Levels of caspase-3 and histidine-rich glycoprotein in the embryo secretome as biomarkers of good-quality day-2 embryos and high-quality blastocysts
por: Kaihola, Helena, et al.
Publicado: (2019)

Pro-angiogenic Role of Insulin: From Physiology to Pathology
por: Escudero, Carlos A., et al.
Publicado: (2017)

The Effect of Antenatal Depression and Selective Serotonin Reuptake Inhibitor Treatment on Nerve Growth Factor Signaling in Human Placenta
por: Kaihola, Helena, et al.
Publicado: (2015)

Advantages in Wound Healing Process in Female Mice Require Upregulation A(2A)-Mediated Angiogenesis under the Stimulation of 17β-Estradiol
por: Troncoso, Felipe, et al.
Publicado: (2020)

The effects of antenatal depression and antidepressant treatment on placental gene expression
por: Olivier, Jocelien D. A., et al.
Publicado: (2015)

Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic Pregnancies
por: Escudero, Carlos A., et al.
Publicado: (2016)

Differences in secretome in culture media when comparing blastocysts and arrested embryos using multiplex proximity assay
por: Lindgren, Karin E., et al.
Publicado: (2018)

Gestational diabetes mellitus is associated with increased pro-migratory activation of vascular endothelial growth factor receptor 2 and reduced expression of vascular endothelial growth factor receptor 1
por: Troncoso, Felipe, et al.
Publicado: (2017)

Pregnancy hypertensive disease and risk of dementia and cardiovascular disease in women aged 65 years or older: a cohort study
por: Nelander, M, et al.
Publicado: (2016)

Increased CSF Levels of Phosphorylated Neurofilament Heavy Protein following Bout in Amateur Boxers
por: Neselius, Sanna, et al.
Publicado: (2013)

Circulating concentrations of glycocalyx degradation products in preeclampsia
por: Carlberg, Niclas, et al.
Publicado: (2022)

Multi-Fetal Pregnancy, Preeclampsia, and Long-Term Cardiovascular Disease
por: Bergman, Lina, et al.
Publicado: (2020)

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
por: Blennow, Kaj, et al.
Publicado: (2010)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
por: Blennow, Kaj, et al.
Publicado: (2015)

The Past and the Future of Alzheimer’s Disease Fluid Biomarkers(1)
por: Blennow, Kaj, et al.
Publicado: (2018)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
por: Zetterberg, Henrik, et al.
Publicado: (2021)

CSF-Biomarkers in Olympic Boxing: Diagnosis and Effects of Repetitive Head Trauma
por: Neselius, Sanna, et al.
Publicado: (2012)

Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers
por: Neselius, Sanna, et al.
Publicado: (2014)

Effects of Fluoxetine on Human Embryo Development
por: Kaihola, Helena, et al.
Publicado: (2016)

Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia
por: Junus, Katja, et al.
Publicado: (2022)

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
por: Mattsson, Niklas, et al.
Publicado: (2010)

Cerebrospinal Fluid Analysis Should Be Considered in Patients with Cognitive Problems
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease
por: Andreasen, Niels, et al.
Publicado: (2010)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
por: Andreasson, Ulf, et al.
Publicado: (2016)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
por: Ashton, Nicholas J., et al.
Publicado: (2021)

Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years
por: Skoog, Ingmar, et al.
Publicado: (2016)

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS
por: Bergman, Joakim, et al.
Publicado: (2016)

Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease
por: Zetterberg, Henrik, et al.
Publicado: (2010)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
por: Skillbäck, Tobias, et al.
Publicado: (2013)

Fluid biomarkers in Alzheimer’s disease – current concepts
por: Rosén, Christoffer, et al.
Publicado: (2013)

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
por: Mattsson, Niklas, et al.
Publicado: (2017)

Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men
por: Benedict, Christian, et al.
Publicado: (2020)

Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
por: Tobieson, Lovisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_innejpi3l9560sfqeumr9mrjd5